Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Immunomedics Company Profile (NASDAQ:IMMU)

Consensus Ratings for Immunomedics (NASDAQ:IMMU) (?)
Ratings Breakdown: 2 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $5.75 (40.24% upside)

Analysts' Ratings History for Immunomedics (NASDAQ:IMMU)
Show:
DateFirmActionRatingPrice TargetActions
1/16/2015Wells Fargo & Co.Initiated CoverageOutperform -> Fair ValueView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2015Wells Fargo & Co.Initiated CoverageOutperform -> Outperform$7.00 -> $7.25View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/30/2014Panmure GordonReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2014Jefferies GroupInitiated CoverageBuy$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/27/2014R. F. LaffertyDowngradeBuy -> Neutral$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2014Chardan CapitalInitiated CoverageBuy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2013OppenheimerBoost Price TargetOutperform$6.00 -> $8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/10/2013R. F. LaffertyInitiated CoverageBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2013WallachBeth CapitalInitiated CoverageBuy$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/23/2013 forward)